UCLA Health researchers have identified a potential drug target for treating Fragile X syndrome, the most common genetic ...
Scientists have created a new therapeutic approach for testing fragile X syndrome, which is the most common genetic cause of autism spectrum disorder (ASD). This method aims to alter a type of neural ...
Please provide your email address to receive an email when new articles are posted on . The FDA has cleared an investigational new drug application for a small molecule therapeutic to treat those with ...
Fragile X syndrome (FXS) and autism spectrum disorder (ASD) sometimes occur together. While FXS is a known genetic cause of ASD, not everyone who receives an FXS diagnosis is autistic, and not all ...
The cover artistically integrates multiple elements central to investigating the developmental origins of Fragile X syndrome. A vibrant DNA double helix structure rendered in rainbow iridescent colors ...
Study found that EPAC2 levels appear to rise gradually as the brain matures, suggesting it may have particular relevance as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results